Close

Oppenheimer Reiterates Outperform on Yum! Brands (YUM) Following 3Q Report

Go back to Oppenheimer Reiterates Outperform on Yum! Brands (YUM) Following 3Q Report

Jefferies Reiterates Hold on Yum! Brands (YUM) Following 3Q Report

October 7, 2016 8:06 AM EDT

Jefferies reiterated a Hold rating and $85.00 price target on Yum! Brands (NYSE: YUM) following the company's 3Q earnings report. YUM reported EPS of $1.09, slightly below the $1.10 consensus estimate. TB and KFC put up good results with 3% sss/9% oper profit growth and +4% sss and 11% oper profit... More

Options with increasing volume: GG YUM QRVO LMT ALNY TK TTWO BLL PEIX SWHC FTNT LRCX

October 6, 2016 9:45 AM EDT

Options with increasing volume: GG YUM QRVO LMT ALNY TK TTWO BLL PEIX SWHC FTNT LRCX

... More

Pre-Open Stock Movers 10/06: (ALQA) (SCYX) (ZUMZ) Higher; (ALNY) (TWTR) (MDCO) Lower (more...)

October 6, 2016 9:22 AM EDT

Today's Pre-Open Stock Movers

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) 44.3% LOWER; announced that upon the recommendation of the ENDEAVOUR Phase 3 study Data Monitoring Committee (DMC) to suspend dosing, the Company has decided to discontinue development of revusiran, an investigational RNA interference (RNAi) therapeutic that was being developed for the treatment of hereditary ATTR amyloidosis with cardiomyopathy (hATTR-CM). This decision was made yesterday evening and has been communicated to investigators, study sites, and regulatory authorities.

Jaguar Animal Health, Inc. (Nasdaq: JAGX)... More

Stocks with Implied Volatility Movement

October 6, 2016 5:33 AM EDT

Yum! Brands (NYSE: YUM) implied volatility is above its IV index mean

... More

After-Hours Stock Movers 10/05: (SCYX) (ZUMZ) (JD) Higher; (ALNY) (IDRA) (MDCO) Lower (more...)

October 5, 2016 6:10 PM EDT

Today's After-Hours Movers

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) 42.3% LOWER; announced that upon the recommendation of the ENDEAVOUR Phase 3 study Data Monitoring Committee (DMC) to suspend dosing, the Company has decided to discontinue development of revusiran, an investigational RNA interference (RNAi) therapeutic that was being developed for the treatment of hereditary ATTR amyloidosis with cardiomyopathy (hATTR-CM). This decision was made yesterday evening and has been communicated to investigators, study sites, and regulatory authorities.

SCYNEXIS, Inc. (Nasdaq: SCYX)... More

Yum! Brands (YUM) Misses Q3 EPS by 1c

October 5, 2016 4:17 PM EDT

Yum! Brands (NYSE: YUM) reported Q3 EPS of $1.09, $0.01 worse than the analyst estimate of $1.10. Revenue for the quarter came in at $3.32 billion versus the consensus estimate of $3.49 billion.

% Change... More

Option volume movers

October 5, 2016 5:24 AM EDT

CBOE Livevol Highest Volume on the Day: SPY SPX GLD GDX BAC AAPL VIX QQQ IWM EEM

CBOE Livevol Above Average Daily Option Volume: AYI MENT NTRI BMO CMRE MIFI EWW GNRC MTDR PENN

... More

Option volume flows

October 5, 2016 5:21 AM EDT

Options expected to have increasing volume: MON YUM STZ SLV MKC

Options with increasing call volume on October 4; EWW GNRC BMO HCA JNK PWR PBYI DRI CLDX PENN

Options with increasing put volume on October 4; RF NBR SAP DRI PH YNDX BG DNKN GIS APOL

... More

Yum Brands (YUM) calls active into Q3 and outlook

October 4, 2016 2:58 PM EDT

Yum! Brands (NYSE: YUM) October weekly call option implied volatility is at 65, October is at 39, November is at 30; compared to its 52-week range of 16 to 41 into the expected release of Q3 results on October 5. October 92 and November 97.5 calls are active on total call volume of 9,560 contracts (3,500 puts).

... More